Jessica Danny Xu Liang

US Patent:

7160296, Jan 9, 2007

Filed:

May 10, 2002

Appl. No.:

10/142713

Inventors:

Rob Pearson - San Jose CA, US
Steve A. Daniel - Fremont CA, US
Daniel J. Balbierz - Redwood City CA, US
Kee S. Lee - Newark CA, US
Jessica Liang - Redwood City CA, US
Martha Getaneh - San Jose CA, US

Assignee:

Rita Medical Systems, Inc. - Mountain View CA

International Classification:

A61B 18/18

US Classification:

606 42, 607102

Abstract:

A tissue-ablation method and apparatus are disclosed. The apparatus includes a plurality of RF ablation electrodes, and a plurality of sensor elements, each movable from retracted to deployed positions in a tissue to be ablated. A control device in the apparatus is operatively connected to the electrodes for supplying an RF power to the electrodes, to produce tissue ablation that advances from individual-electrode ablation regions to fill a combined-electrode ablation volume. The control device is operatively connected to the sensor elements for determining the extent of ablation in the regions of the sensor elements. The supply of RF power to the electrodes can thus be regulated to control the level and extent of tissue ablation throughout the combined-electrode volume. The electrodes are preferably hollow-needle electrodes through which liquid can be infused into the tissue, also under the control of the control unit, to modulate and optimize tissue ablation.

US Patent:

8163704, Apr 24, 2012

Filed:

Oct 18, 2010

Appl. No.:

12/906682

Inventors:

Gregory Raymond Bebernitz - Stow MA, US
Mark G. Bock - Boston MA, US
Dumbala Srinivas Reddy - Andhra Pradesh, IN
Atul Kashinath Hajare - Maharashtra, IN
Vinod Vyavahare - Bangalore, IN
Sandeep Bhausaheb Bhosale - Maharashtra, IN
Suresh Eknath Kurhade - Maharashtra, IN
Videsh Salunkhe - Bangalore, IN
Nadim S. Shaikh - Bangalore, IN
Debnath Bhuniya - West Bengal, IN
P. Venkata Palle - Maharashtra, IN
Lili Feng - Pine Brook NJ, US
Jessica Liang - Annandale NJ, US

Assignee:

Novartis AG - Basel

International Classification:

A01N 43/04
A61K 31/70
C07H 1/00

US Classification:

514 23, 536 111

Abstract:

This invention relates to compounds represented by formula (I):.

US Patent:

8466114, Jun 18, 2013

Filed:

Mar 21, 2012

Appl. No.:

13/425888

Inventors:

Gregory Raymond Bebernitz - Stow MA, US
Mark G. Bock - Boston MA, US
Dumbala Srinivas Reddy - Hyderabad, IN
Atul Kashinath Hajare - Ahmednagar, IN
Vinod Vyavahare - Bangalore, IN
Sandeep Bhausaheb Bhosale - Pune, IN
Suresh Eknath Kurhade - Pune, IN
Videsh Salunkhe - Bangalore, IN
Nadim S. Shaikh - Bangalore, IN
Debnath Bhuniya - Howrah, IN
P. Venkata Palle - Pune, IN
Lili Feng - Pine Brook NJ, US
Jessica Liang - Annandale NJ, US

Assignee:

Novartis AG - Basel

International Classification:

A01N 43/04
A61K 31/70

US Classification:

514 23

Abstract:

This invention relates to compounds represented by formula (I):.

US Patent:

20070112342, May 17, 2007

Filed:

Jan 8, 2007

Appl. No.:

11/651123

Inventors:

Rob Pearson - San Jose CA, US
Steve Daniel - Fremont CA, US
Daniel Balbierz - Redwood City CA, US
Kee Lee - Newark CA, US
Jessica Liang - Redwood City CA, US
Martha Getaneh - San Jose CA, US

International Classification:

A61B 18/18

US Classification:

606034000, 606041000

Abstract:

A method and apparatus for controlling the extent of tissue ablation are disclosed. The method utilizes delivering energy from an energy deliver device to a plurality of deployed electrodes and regulating energy delivered to the electrodes based on the temperature sensed by at least one remote elongate sensor element. A control device may be used to supply energy to the electrodes, to produce tissue ablation that advances from individual-electrode ablation regions to fill a combined-electrode ablation volume. Information from the sensor element(s) is used for determining the extent of ablation in the regions of the sensor elements. The supply of energy to the electrodes can thus be regulated to control the level and extent of tissue ablation throughout the combined-electrode volume.

US Patent:

20100030200, Feb 4, 2010

Filed:

Apr 16, 2007

Appl. No.:

12/297419

Inventors:

Brian Michael Strauss - Trabuco Canyon CA, US
Earl Howard Slee - Laguna Niguel CA, US
Ramon Torres Carrillo - Santa Ana CA, US
Khoa Dang Vu - Santa Ana CA, US
William Robert Patterson - Irvine CA, US
Jessica Liang - Irvine CA, US
Richard Stephen Bein - San Clemente CA, US
Todd Jeffrey Hewitt - Laguna Niguel CA, US
Stacy Leon Faught - Aliso Viejo CA, US
Vince Divino - Mission Viejo CA, US
Darrell Christopher Drysen - Irvine CA, US
Mark Philip Ashby - Laguna Niguel CA, US
Justin Arthur Klotz - Los Angeles CA, US
Maria De Jesus Sanson - San Clemente CA, US
Scott William Brennan - Laguna Beach CA, US
Lawrason Charles Wilbur - Lake Forest CA, US
Lester Eugene Oestreich - Norwalk CA, US

International Classification:

A61B 17/00

US Classification:

606 1

Abstract:

An intravascular implant delivery system carries an implant by retaining an engagement member engaging the implant in a position proximal of an aperture at a distal end of the delivery system. The engagement member is retained proximal to the aperture by a cord that obstructs the movement of the engagement member through the aperture. The engagement member is free to rotate and move within an area defined by the delivery system, allowing the implant to react to forces imparted to the implant by the movement of the delivery system and implant through a delivery catheter. Once the implant is in a desired implant position, the cord is moved away from an aperture and the engagement member is allowed to move away from the delivery system.

US Patent:

20110313447, Dec 22, 2011

Filed:

Aug 30, 2011

Appl. No.:

13/221852

Inventors:

Brian Michael Strauss - Trabuco Canyon CA, US
Earl Howard Slee - Laguna Niguel CA, US
Ramon Torres Carrillo - Santa Ana CA, US
Khoa Dang Vu - Santa Ana CA, US
William Robert Patterson - Irvine CA, US
Jessica Liang - Irvine CA, US
Richard Stephen Bein - San Clemente CA, US
Todd Jeffrey Hewitt - Laguna Niguel CA, US
Stacy Leon Faught - Aliso Viejo CA, US
Vince Divino - Mission Viejo CA, US
Darrell Christopher Drysen - Irvine CA, US
Mark Philip Ashby - Laguna Niguel CA, US
Justin Arthur Klotz - Los Angeles CA, US
Maria De Jesus Sanson - San Clemente CA, US
Scott William Brennan - Laguna Beach CA, US
Lawrason Charles Wilbur - Lake Forest CA, US
Lester Eugene Oestreich - Norwalk CA, US

Assignee:

Tyco Healthcare Group LP, as successor in interest to Micro Therapeutics, Inc. - Irvine CA

International Classification:

A61F 2/01

US Classification:

606200

Abstract:

An intravascular implant delivery system carries an implant by retaining an engagement member engaging the implant in a position proximal of an aperture at a distal end of the delivery system. The engagement member is retained proximal to the aperture by a cord that obstructs the movement of the engagement member through the aperture. The engagement member is free to rotate and move within an area defined by the delivery system, allowing the implant to react to forces imparted to the implant by the movement of the delivery system and implant through a delivery catheter. Once the implant is in a desired implant position, the cord is moved away from an aperture and the engagement member is allowed to move away from the delivery system.

US Patent:

20120065720, Mar 15, 2012

Filed:

Aug 30, 2011

Appl. No.:

13/221843

Inventors:

Brian Michael Strauss - Trabuco Canyon CA, US
Earl Howard Slee - Laguna Niguel CA, US
Ramon Torres Carrillo - Santa Ana CA, US
Khoa Dang Vu - Santa Ana CA, US
William Robert Patterson - Irvine CA, US
Jessica Liang - Irvine CA, US
Richard Stephen Bein - San Clemente CA, US
Todd Jeffrey Hewitt - Laguna Niguel CA, US
Stacy Leon Faught - Aliso Viejo CA, US
Vince Divino - Mission Viejo CA, US
Darrell Christopher Drysen - Irvine CA, US
Mark Philip Ashby - Laguna Niguel CA, US
Justin Arthur Klotz - Los Angeles CA, US
Maria De Jesus Sanson - San Clemente CA, US
Scott William Brennan - Laguna Beach CA, US
Lawrason Charles Wilbur - Lake Forest CA, US
Lester Eugene Oestreich - Norwalk CA, US

Assignee:

Tyco Healthcare Group LP, as successor in interest to Micro Therapeutics,Inc. - Irvin CA

International Classification:

A61F 2/84

US Classification:

623 111

Abstract:

An intravascular implant delivery system carries an implant by retaining an engagement member engaging the implant in a position proximal of an aperture at a distal end of the delivery system. The engagement member is retained proximal to the aperture by a cord that obstructs the movement of the engagement member through the aperture. The engagement member is free to rotate and move within an area defined by the delivery system, allowing the implant to react to forces imparted to the implant by the movement of the delivery system and implant through a delivery catheter. Once the implant is in a desired implant position, the cord is moved away from an aperture and the engagement member is allowed to move away from the delivery system.

US Patent:

20120226305, Sep 6, 2012

Filed:

Aug 30, 2011

Appl. No.:

13/221848

Inventors:

Brian Michael Strauss - Trabuco Canyon CA, US
Earl Howard Slee - Laguna Niguel CA, US
Ramon Torres Carrillo - Santa Ana CA, US
Khoa Dang Vu - Santa Ana CA, US
William Robert Patterson - Irvine CA, US
Jessica Liang - Irvine CA, US
Richard Stephen Bein - San Clemente CA, US
Todd Jeffrey Hewitt - Laguna Niguel CA, US
Stacy Leon Faught - Aliso Viejo CA, US
Vince Divino - Mission Viejo CA, US
Darrell Christopher Drysen - Irvine CA, US
Mark Philip Ashby - Laguna Niguel CA, US
Justin Arthur Klotz - Los Angeles CA, US
Maria De Jesus Sanson - San Clemente CA, US
Scott William Brennan - Laguna Beach CA, US
Lawrason Charles Wilbur - Lake Forest CA, US
Lester Eugene Oestreich - Norwalk CA, US

Assignee:

Tyco Healthcare Group LP, as successor in interest to Micro Therapeutics, Inc. - Irvine CA

International Classification:

A61F 2/01

US Classification:

606200

Abstract:

An intravascular implant delivery system carries an implant by retaining an engagement member engaging the implant in a position proximal of an aperture at a distal end of the delivery system. The engagement member is retained proximal to the aperture by a cord that obstructs the movement of the engagement member through the aperture. The engagement member is free to rotate and move within an area defined by the delivery system, allowing the implant to react to forces imparted to the implant by the movement of the delivery system and implant through a delivery catheter. Once the implant is in a desired implant position, the cord is moved away from an aperture and the engagement member is allowed to move away from the delivery system.